ProfileGDS4132 / 232746_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 27% 25% 29% 21% 27% 25% 23% 25% 26% 31% 35% 32% 32% 31% 34% 29% 30% 34% 32% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10164.791627
GSM201543Muscle PCOS pioglitazone 12152.636725
GSM201544Muscle PCOS pioglitazone 16172.598329
GSM201545Muscle PCOS pioglitazone 20154.546621
GSM201829Muscle PCOS pioglitazone 23169.851627
GSM201830Muscle PCOS pioglitazon 25161.671925
GSM201831Muscle PCOS pioglitazone 27149.457623
GSM201832Muscle PCOS pioglitazone 3161.385325
GSM201833Muscle PCOS pioglitazone 4159.650326
GSM201834Muscle PCOS pioglitazone 8175.592631
GSM201835Muscle PCOS after pioglitazone 10274.201735
GSM201836Muscle PCOS after pioglitazone 12268.801432
GSM201837Muscle PCOS after pioglitazone 16264.850132
GSM201838Muscle PCOS after pioglitazone 20266.86331
GSM201839Muscle PCOS after pioglitazone 23278.943934
GSM201840Muscle PCOS after pioglitazone 25268.594229
GSM201841Muscle PCOS after pioglitazone 27258.836530
GSM201842Muscle PCOS after pioglitazone 3268.370234
GSM201843Muscle PCOS after pioglitazone 4278.280732
GSM201844Muscle PCOS after pioglitazone 82104.46842